vs

Side-by-side financial comparison of Dexcom (DXCM) and Lamb Weston (LW). Click either name above to swap in a different company.

Lamb Weston is the larger business by last-quarter revenue ($1.6B vs $1.3B, roughly 1.2× Dexcom). Dexcom runs the higher net margin — 21.2% vs 3.5%, a 17.8% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 2.9%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -1.5%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Lamb Weston Holdings, Inc. is an American food processing company that is one of the world's largest producers and processors of frozen french fries, waffle fries, and other frozen potato products. It is headquartered in Eagle, Idaho, a suburb of Boise.

DXCM vs LW — Head-to-Head

Bigger by revenue
LW
LW
1.2× larger
LW
$1.6B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+18.7% gap
DXCM
21.6%
2.9%
LW
Higher net margin
DXCM
DXCM
17.8% more per $
DXCM
21.2%
3.5%
LW
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-1.5%
LW

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
DXCM
DXCM
LW
LW
Revenue
$1.3B
$1.6B
Net Profit
$267.3M
$54.0M
Gross Margin
62.9%
21.2%
Operating Margin
25.6%
8.1%
Net Margin
21.2%
3.5%
Revenue YoY
21.6%
2.9%
Net Profit YoY
153.6%
-63.0%
EPS (diluted)
$0.67
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
LW
LW
Q1 26
$1.3B
$1.6B
Q4 25
$1.3B
$1.6B
Q3 25
$1.2B
$1.7B
Q2 25
$1.2B
$1.7B
Q1 25
$1.0B
$1.5B
Q4 24
$1.1B
$1.6B
Q3 24
$994.2M
$1.7B
Q2 24
$1.0B
$1.6B
Net Profit
DXCM
DXCM
LW
LW
Q1 26
$267.3M
$54.0M
Q4 25
$267.3M
$62.1M
Q3 25
$283.8M
$64.3M
Q2 25
$179.8M
$119.9M
Q1 25
$105.4M
$146.0M
Q4 24
$151.7M
$-36.1M
Q3 24
$134.6M
$127.4M
Q2 24
$143.5M
$129.6M
Gross Margin
DXCM
DXCM
LW
LW
Q1 26
62.9%
21.2%
Q4 25
62.9%
20.0%
Q3 25
60.5%
20.6%
Q2 25
59.5%
20.4%
Q1 25
56.9%
27.8%
Q4 24
58.9%
17.4%
Q3 24
59.7%
21.5%
Q2 24
62.4%
24.1%
Operating Margin
DXCM
DXCM
LW
LW
Q1 26
25.6%
8.1%
Q4 25
25.6%
8.6%
Q3 25
20.1%
9.4%
Q2 25
18.4%
11.1%
Q1 25
12.9%
16.4%
Q4 24
17.0%
1.2%
Q3 24
15.3%
12.8%
Q2 24
15.7%
13.2%
Net Margin
DXCM
DXCM
LW
LW
Q1 26
21.2%
3.5%
Q4 25
21.2%
3.8%
Q3 25
23.5%
3.9%
Q2 25
15.5%
7.2%
Q1 25
10.2%
9.6%
Q4 24
13.6%
-2.3%
Q3 24
13.5%
7.7%
Q2 24
14.3%
8.0%
EPS (diluted)
DXCM
DXCM
LW
LW
Q1 26
$0.67
$0.39
Q4 25
$0.67
$0.44
Q3 25
$0.70
$0.46
Q2 25
$0.45
$0.84
Q1 25
$0.27
$1.03
Q4 24
$0.37
$-0.25
Q3 24
$0.34
$0.88
Q2 24
$0.35
$0.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
LW
LW
Cash + ST InvestmentsLiquidity on hand
$917.7M
$57.5M
Total DebtLower is stronger
$3.6B
Stockholders' EquityBook value
$2.7B
$1.8B
Total Assets
$6.3B
$7.4B
Debt / EquityLower = less leverage
1.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
LW
LW
Q1 26
$917.7M
$57.5M
Q4 25
$917.7M
$82.7M
Q3 25
$1.8B
$98.6M
Q2 25
$1.2B
$70.7M
Q1 25
$904.9M
$67.5M
Q4 24
$606.1M
$79.0M
Q3 24
$621.2M
$120.8M
Q2 24
$939.2M
$71.4M
Total Debt
DXCM
DXCM
LW
LW
Q1 26
$3.6B
Q4 25
$3.6B
Q3 25
$3.7B
Q2 25
$3.7B
Q1 25
$3.7B
Q4 24
$3.7B
Q3 24
$3.4B
Q2 24
$3.4B
Stockholders' Equity
DXCM
DXCM
LW
LW
Q1 26
$2.7B
$1.8B
Q4 25
$2.7B
$1.8B
Q3 25
$2.7B
$1.8B
Q2 25
$2.6B
$1.7B
Q1 25
$2.3B
$1.6B
Q4 24
$2.1B
$1.6B
Q3 24
$2.0B
$1.8B
Q2 24
$2.4B
$1.8B
Total Assets
DXCM
DXCM
LW
LW
Q1 26
$6.3B
$7.4B
Q4 25
$6.3B
$7.3B
Q3 25
$7.5B
$7.2B
Q2 25
$7.3B
$7.4B
Q1 25
$6.8B
$7.4B
Q4 24
$6.5B
$7.5B
Q3 24
$6.4B
$7.5B
Q2 24
$6.8B
$7.4B
Debt / Equity
DXCM
DXCM
LW
LW
Q1 26
1.99×
Q4 25
2.08×
Q3 25
2.05×
Q2 25
2.12×
Q1 25
2.25×
Q4 24
2.26×
Q3 24
1.87×
Q2 24
1.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
LW
LW
Operating Cash FlowLast quarter
$65.2M
Free Cash FlowOCF − Capex
$-36.3M
FCF MarginFCF / Revenue
-2.3%
Capex IntensityCapex / Revenue
6.5%
Cash ConversionOCF / Net Profit
1.21×
TTM Free Cash FlowTrailing 4 quarters
$569.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
LW
LW
Q1 26
$65.2M
Q4 25
$294.0M
$178.4M
Q3 25
$659.9M
$352.0M
Q2 25
$303.0M
$868.3M
Q1 25
$183.8M
$56.0M
Q4 24
$301.4M
$99.1M
Q3 24
$199.5M
$330.2M
Q2 24
$279.4M
$798.2M
Free Cash Flow
DXCM
DXCM
LW
LW
Q1 26
$-36.3M
Q4 25
$192.1M
$101.0M
Q3 25
$579.4M
$274.4M
Q2 25
$208.9M
$230.1M
Q1 25
$96.8M
$-19.8M
Q4 24
$176.8M
$-49.6M
Q3 24
$88.3M
$4.3M
Q2 24
$213.3M
$-131.3M
FCF Margin
DXCM
DXCM
LW
LW
Q1 26
-2.3%
Q4 25
15.3%
6.2%
Q3 25
47.9%
16.5%
Q2 25
18.1%
13.7%
Q1 25
9.3%
-1.3%
Q4 24
15.9%
-3.1%
Q3 24
8.9%
0.3%
Q2 24
21.2%
-8.1%
Capex Intensity
DXCM
DXCM
LW
LW
Q1 26
6.5%
Q4 25
8.1%
4.8%
Q3 25
6.7%
4.7%
Q2 25
8.1%
38.1%
Q1 25
8.4%
5.0%
Q4 24
11.2%
9.3%
Q3 24
11.2%
19.7%
Q2 24
6.6%
57.7%
Cash Conversion
DXCM
DXCM
LW
LW
Q1 26
1.21×
Q4 25
1.10×
2.87×
Q3 25
2.33×
5.47×
Q2 25
1.69×
7.24×
Q1 25
1.74×
0.38×
Q4 24
1.99×
Q3 24
1.48×
2.59×
Q2 24
1.95×
6.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

LW
LW

Segments North America$1.0B66%
Segments International$529.8M34%

Related Comparisons